Brief: Orexo Announces Positive Topline Results From Clinical Study

Orexo AB

10/01/2025 07:04

Jan 10 (Reuters) - Orexo AB  ORX.ST :
    * ANNOUNCES POSITIVE TOPLINE RESULTS FROM CLINICAL STUDY
OX640-002
    * SYSTEMIC SAFETY WAS IN LINE WITH KNOWN PHARMACOLOGY OF
EPINEPHRINE AND LOCAL EFFECTS WERE TRANSIENT AND TOLERATED
    * THERE WERE NO SEVERE OR SERIOUS ADVERSE EVENTS

Source text:  ID:nMFN9C1M6Y 
Further company coverage:  ORX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))